Ionis announces Dr. Frank Bennett, chief scientific officer, to retire
Ionis Pharmaceuticals announced that Dr. Frank Bennett, executive vice president and chief scientific officer, will retire effective February 2027. Bennett will serve as a strategic consultant during the transition, and his responsibilities will be assumed by Eric Swayze, Ph.D., executive vice president and head of research.
Key figures
- Us patents
- 200+
- Drugs approved
- 7
- Retirement date
- February 2027
- Candidates discovered
- 50+
- Peer reviewed manuscripts
- 240+
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.